Akanda Corp. (AKAN)

GB — Healthcare Sector
Peers: SXTC  PTPI  GSAC  SHPH  DBCCF  CXXIF  CLSH  GRUSF  SLGWF  LSDI  LFCR  DERM  CPHI  UPC  SNOA  ACOR  BFRI  GHSI 

Automate Your Wheel Strategy on AKAN

With Tiblio's Option Bot, you can configure your own wheel strategy including AKAN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AKAN
  • Rev/Share 0.8029
  • Book/Share 4.1041
  • PB 0.2948
  • Debt/Equity 0.0825
  • CurrentRatio 1.3898
  • ROIC -0.9467

 

  • MktCap 2753844.0
  • FreeCF/Share -4.3421
  • PFCF -0.6086
  • PE -0.3078
  • Debt/Assets 0.0446
  • DivYield 0
  • ROE -0.926

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Akanda Corp. (AKAN)

  • IPO Date 2022-03-15
  • Website https://www.akandacorp.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Ms. Katharyn Field
  • Employees 46
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.